Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (5)
Type
(
1 selected
)
Type
Guidance (373)
NICE advice (1)
Quality standard (8)
Guidance programme
Guidance programme
Clinical guidelines (25)
Diagnostics guidance (6)
Health technology evaluations (14)
Highly specialised technologies guidance (5)
Interventional procedures guidance (15)
Medical technologies guidance (8)
NICE guidelines (30)
Public health guidelines (1)
Technology appraisal guidance (300)
Apply filters
Showing 271 to 280 of 373
Sort by
Title
Date
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Psoriasis: assessment and management (CG153)
NICE guideline
TBC
Psoriasis: assessment and management - Topical therapy
NICE guideline
TBC
Pulmonary artery pressure technologies for remote monitoring of chronic heart failure
Diagnostics guidance
20 January 2026
Ravulizumab for untreated thrombotic microangiopathy after a haematopoietic stem cell transplant in people aged 28 days and over [TSID10642][ID6319]
Technology appraisal guidance
TBC
Regorafenib for treating advanced gastrointestinal stromal tumours [ID1056]
Technology appraisal guidance
15 November 2017
Rehabilitation for chronic neurological disorders including acquired brain injury
NICE guideline
15 October 2025
Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines ID6356
Technology appraisal guidance
TBC
Renal cell carcinoma Pathways Pilot [ID6186]
Technology appraisal guidance
TBC
Repotrectinib for treating NTRK fusion-positive advanced solid tumours in people 12 years and over [TSID12147]
Technology appraisal guidance
TBC
Repotrectinib for treating ROS1-positive advanced non-small-cell lung cancer [ID6277]
Technology appraisal guidance
TBC
Previous page
1
…
26
27
Current page
28
29
30
…
38
Page
28
of
38
Next page
Results per page
10
25
50
All
Back to top